C
BMY icon

Certuity’s Bristol-Myers Squibb BMY Stock Holding History

Certuity’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,000
Closed -$121K – 256
2020
Q3 		$121K Hold
2,000
– – 0.05% 188
2020
Q2 		$118K Hold
2,000
– – 0.05% 173
2020
Q1 		$111K Buy
+2,000
New +$122K 0.06% 155

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Certuity's BMY Position: Q2 2026 in Review

Certuity reduced its Bristol-Myers Squibb (BMY) stake by 0.33% in Q2 2026, selling an estimated $22.1K and leaving 116,698 shares worth $6.72M. The position accounts for 0.33% of the portfolio, ranked #47.

Certuity first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. The position peaked at $7.78M in Q3 2024. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Certuity held 116,698 shares of Bristol-Myers Squibb worth $6.72M as of Q2 2026.
  • Certuity sold 384 Bristol-Myers Squibb shares in Q2 2026, an estimated $22.1K.
  • Bristol-Myers Squibb made up 0.33% of Certuity's portfolio in Q2 2026, its #47 holding.
  • Certuity first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
  • Certuity's Bristol-Myers Squibb position peaked at $7.78M in Q3 2024.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.